Xianbin Yang

Dr. Yang has 30+ years of nucleic acid drug discovery and development experience. Prior to joining Sirnaomics, he was a founding member of several biotechnology companies in the United States, where he initiated numerous pre-clinical therapeutics programs. He also served as an advisor for several international companies, a program reviewer for 3 NIH study sections and 8 journals, in addition to an adjunct professor for 3 universities. He was the PI for 13 highly competitive national awarded grants, an inventor with 4 awarded patents, and the author for of 73 publications. Dr. Yang also received various academic and professional awards. At Sirnaomics, he oversees the nucleic acid pharmaceutical chemistry program for RNAi drug enabling, identify new RNA therapeutic targets, develop new collaboration programs, and lead the CMC in China.